Finasteride
Back to searchMolecule Structure
Scientific Name
Finasteride
Description of the Drug
Finasteride is an antiandrogenic compound that is used for the treatment of symptomatic benign prostatic hyperplasia (BPH) and male pattern hair loss in adult males by inhibiting Type II 5-alpha reductase.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01216
http://www.drugbank.ca/drugs/DB01216
Brand Name(s)
Aindeem, Finasteride, Propecia, Proscar, Prostide
Company Owner(s)
Organon Llc A Sub Of Organon And Co, Cipla Ltd, Teva Pharmaceuticals Usa Inc, Alkem Laboratories Ltd, Sun Pharmaceutical Industries Ltd, Actavis Totowa Llc, Hetero Labs Ltd Unit Iii, Accord Healthcare Inc, Aurobindo Pharma Ltd, Veru Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Steroid 5-alpha-reductase 2 | SINGLE PROTEIN | INHIBITOR | CHEMBL1856 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL5509 | ||
| PharmGKB | PA449627 | ||
| Human Metabolome Database | HMDB0001984 | ||
| DrugBank | DB01216 | ||
| PubChem: Thomson Pharma | 14779683 | 14926633 | |
| PubChem | 57363 | ||
| LINCS | LSM-1999 | ||
| Nikkaji | J367.472J | ||
| PDBe | FIT | ||
| BindingDB | 50334788 | ||
| EPA CompTox Dashboard | DTXSID3020625 | ||
| DrugCentral | 1171 | ||
| Brenda | 40816 | 1012 | 132256 |
| ChemicalBook | CB9433852 | ||
| Guide to Pharmacology | 6818 | ||
| rxnorm | PROPECIA | PROSCAR | FINASTERIDE |
| PubChem: Drugs of the Future | 12014292 | ||
| ChEBI | 5062 | ||
| ZINC | ZINC000003782599 |
